Method development & validation
SYMBIOSIS offers the development of new, and optimization of existing methods such as HPLC, SDS-PAGE and ELISA for (bio-) pharmaceuticals. We focus on your individual requirements, delivering personalised solutions for every analytical challenge.
Method validation according to ICH guideline Q2 is being performed upon successful establishment by request. For follow up analyses we can be the contract lab of your choice for planned stability or release studies including controlled storage of your stability study test items. Alternatively, method transfer is being provided for implementation in your lab.
We have a proven track record for method establishment and validation throughout many years. Profit from our reliable expertise in that very important field of quality control of (bio-) pharmaceuticals!
We are your partner for analyses of:
- Antibodies
- Recombinant proteins
- Peptides
- New chemical entities
Contact us

